American Well Co. (NYSE:AMWL – Get Rating) CEO Ido Schoenberg sold 50,943 shares of the stock in a transaction on Monday, September 12th. The shares were sold at an average price of $4.25, for a total value of $216,507.75. Following the completion of the transaction, the chief executive officer now owns 1,752,870 shares of the company's stock, valued at approximately $7,449,697.50. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Ido Schoenberg also recently made the following trade(s):
Get
American Well alerts:
- On Friday, September 9th, Ido Schoenberg sold 259,000 shares of American Well stock. The shares were sold at an average price of $4.36, for a total value of $1,129,240.00.
- On Monday, August 1st, Ido Schoenberg sold 10,295 shares of American Well stock. The shares were sold at an average price of $4.03, for a total value of $41,488.85.
- On Friday, July 1st, Ido Schoenberg sold 300,000 shares of American Well stock. The shares were sold at an average price of $4.39, for a total value of $1,317,000.00.
- On Tuesday, June 21st, Ido Schoenberg sold 136,472 shares of American Well stock. The stock was sold at an average price of $4.61, for a total value of $629,135.92.
American Well Stock Performance
American Well stock opened at $4.03 on Wednesday. The firm has a market cap of $1.10 billion, a P/E ratio of -4.53 and a beta of -0.06. The business's fifty day moving average is $4.53 and its two-hundred day moving average is $4.04. American Well Co. has a 52 week low of $2.52 and a 52 week high of $11.40.
American Well (NYSE:AMWL – Get Rating) last posted its quarterly earnings data on Thursday, August 4th. The company reported ($0.25) EPS for the quarter, topping analysts' consensus estimates of ($0.26) by $0.01. The company had revenue of $64.52 million for the quarter, compared to analyst estimates of $64.13 million. American Well had a negative return on equity of 19.36% and a negative net
margin of 90.47%. The business's revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.15) earnings per share. On average, equities research analysts predict that American Well Co. will post -0.99 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on AMWL shares. Piper Sandler cut their price target on American Well from $6.00 to $5.00 in a report on Wednesday, September 7th. Truist Financial started coverage on American Well in a research report on Wednesday, September 7th. They set a "hold" rating and a $5.00 price objective on the stock. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $8.50.
Hedge Funds Weigh In On American Well
Large investors have recently made changes to their positions in the company. Nisa Investment Advisors LLC lifted its stake in shares of American Well by 440.0% during the first quarter. Nisa Investment Advisors LLC now owns 8,100 shares of the company's stock valued at $34,000 after acquiring an additional 6,600 shares during the period. Point72 Hong Kong Ltd lifted its stake in shares of American Well by 175.1% during the first quarter. Point72 Hong Kong Ltd now owns 8,087 shares of the company's stock valued at $34,000 after acquiring an additional 5,147 shares during the period. Vigilant Capital Management LLC acquired a new position in shares of American Well during the first quarter valued at $42,000. US Bancorp DE lifted its stake in shares of American Well by 605.2% during the second quarter. US Bancorp DE now owns 9,556 shares of the company's stock valued at $42,000 after acquiring an additional 8,201 shares during the period. Finally, Mackenzie Financial Corp bought a new stake in American Well in the first quarter valued at about $43,000. Institutional investors and hedge funds own 46.62% of the company's stock.
About American Well
(Get Rating)
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.
Read More
- Get a free copy of the StockNews.com research report on American Well (AMWL)
- These 3 Reports Will Tell Us Much About the Current Economy
- Is Five Below Trying to Punch Too High?
- This Is What To Expect From The S&P 500 Now
- The Two Things You Need To Know About Oracle's FQ1 Report
- Three Value Stocks For A Volatile Market
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.
